Peroxisome proliferator-activated receptor (PPAR)-α activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats. Comparison with PPAR-γ activation

Diabetes

Volumn 50, Issue 2, 2001, Pages 411-417

  Ye, Ji Ming ^a   Doyle, Patrick J ^b,c   Iglesias, Miguel A ^a   Watson, David G ^a   Cooney, Gregory J ^a   Kraegen, Edward W ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b NOVO NORDISK A S   (Denmark)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; LIPID; LONG CHAIN FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; PIRINIXIC ACID; RECEPTOR SUBTYPE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORRELATION FUNCTION; GLUCOSE METABOLISM; INSULIN SENSITIVITY; LIPID DIET; LIPID METABOLISM; LIPID STORAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; WEIGHT GAIN;

EID: 0035141142     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.2.411     Document Type: Article

References (41)

1. High-fat feeding impairs insulin-stimulated GLUT4 recruitment via an early insulin-signaling defect
2. Five-hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rat
3. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C θ and alterations in the insulin signaling cascade
4. DHEA protects against visceral obesity and muscle insulin resistance in rats fed a high-fat diet
5. The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM
6. PPAR-γ: Adipogenic regulator and thiazolidinedione receptor
7. Roles of PPARs in health and disease
8. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-α in humans: No alteration in adipose tissue of obese and NIDDM patients
9. Convergence of 9-cis retinoíc acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors
10. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay
11. Drag treatment of lipid disorders
12. Improvement of glucose tolerance in NIDDM by clofibrate: Randomized double-blind study
13. Effects of gemfibrozil on insulin sensitivity and on haemostatic variables in hypertriglyceridemic patients
14. Decreasing triglyceride by gemfibrozil therapy does not affect the glucoregulatory or antilipolytic effect of insulin in nondiabetic subjects with mild hypertriglyceridemia
15. Effects of gemfibrozil therapy on glucose tolerance, insulin sensitivity and plasma plasminogen activator inhibitor activity in hypertriglyceridaemia
16. Improved insulin sensitivity by bezafibrate in rats: Relationship to fatty acid composition of skeletal-muscle triglycerides
17. Novel peroxisome proliferator-activated receptor (PPAR) γ and PPARδ ligands produce distinct biological effects
18. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding
19. Dose-response curves for in vivo insulin sensitivity in individual tissues in rats
20. Diet-induced muscle insulin resistance in rats is ameliorated by acute dietary lipid withdrawal or a single bout of exercise: Parallel relationship between insulin stimulation of glucose uptake and suppression of long-chain fatty acyl-CoA
21. The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat
22. Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle
23. Growth hormone-induced insulin resistance and its relationship to lipid availability in the rat
24. Effects of individual fatty acids on glucose uptake and glycogen synthesis in soleus muscle in vitro
25. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate
26. Muscle lipid accumulation and protein kinase C activation in the insulin-resistant chronically glucose-infused rat
27. Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling
28. Mechanism of palmityl coenzyme A inhibition of liver glycogen synthase
29. Activation of protein kinase C alpha inhibits signaling by members of the insulin receptor family
30. Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: Relation to insulin resistance
31. Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARγ agonist) action
32. Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARα and PPARγ activators
33. Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes
34. The glucose fatty acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus
35. Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM
36. Surgical removal of visceral fat reverses hepatic insulin resistance
37. Decreased visceral adiposity accounts for leptin effect on hepatic but not peripheral insulin action
38. Peroxisome proliferator-activated receptor alpha: Role in rodent liver cancer and species differences
39. Species differences in induction of hepatic enzymes by BM 17.0744, an activator of peroxisome proliferator-activated receptor alpha (PPARα)
40. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
41. Peroxisome proliferator-activated receptor α activators improve insulin sensitivity and reduce adiposity